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ABSTRACT 
Background: In moderate acute malnutrition (MAM) programs, it is common practice not to 
measure mid-upper arm circumference (MUAC) of children whose length is<67 cm. This is based 
on expert opinion that supplementation of shorter children with low MUAC and weight-for-height 
z-score (WHZ)≥-2 may increase risk of excessive fat accumulation. Our aim was to assess if shorter 
children gain more fat than taller children when treated for MAM diagnosed by low MUAC alone. 
Methods: This observational study included children aged 6-23 months with MUAC between 115-
125 mm and WHZ ≥-2. Based on length at admission, children were categorized as SHORT if<67 
cm and LONG if≥67 cm. Linear mixed-effects models were used to assess body composition based 
on deuterium dilution and skinfold-thickness.  
Results: Following 12 weeks of supplementation, there was no difference in change in fat mass 
index (-0.038kg/m
2
, 95%CI -0.257;0.181, p=0.74) or fat-free mass index (0.061kg/m
2
, 95%CI -
0.150;0.271; p=0.57) in SHORT vs LONG. In absolute terms, the SHORT children gained both less 
fat-free mass (-230g, 95%CI: -355;-106, P<0.001) and fat mass (-97g, 95%CI -205;10, p=0.076). 
There were no difference in changes in absolute subscapular and triceps skinfold-thickness and z-
scores (p>0.5). 
Conclusions: SHORT children with low MUAC do not gain excessive fat during supplementation. 
These data support a recommendation for policy change to include all children ≥6 months with low 
MUAC in supplementary feeding programs, regardless of length. The use of length as a criterion for 
measuring MUAC to determine treatment eligibility should be discontinued in policy and practice.  
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INTRODUCTION 
Childhood malnutrition contributes to almost half the mortality in children under five years 
1
. 
Moderate acute malnutrition (MAM) is currently defined as weight-for-height z-score (WHZ) 
between –3 and –2 (i.e. moderate wasting), and/or mid-upper arm circumference (MUAC) between 
115 and 125 mm 
2
. While the prevalence of MAM is unknown, moderate wasting alone affects 33 
million children at any time 
3
 and is associated with a three-fold increased risk of death 
4
. 
Protocols for management of acute malnutrition in many African countries (including Cameroon, 
Central African Republic, Chad, Guinea, Ivory Coast, Mali, Mauritania, Senegal, and Togo) instruct 
health personnel to measure MUAC only of children with length ≥67 cm when assessing eligibility 
for MAM or severe acute malnutrition (SAM) treatment programs 
5–13
. In Ethiopia, admission by 
MUAC alone for SAM treatment is restricted to children with lengths >65 cm 
14
. These shorter 
children are enrolled in treatment only if they meet WHZ criterion, which is less closely linked to 
the risk of death and misses high-risk children who would have been identified by MUAC. Hence, 
current practice excludes short children who would benefit from nutritional support.  
The practice of restricting treatment admission by MUAC alone to children of length ≥67 cm is not 
supported by data and has never been formally endorsed by the World Health Organization (WHO). 
Two reasons can be identified to explain this exclusion. First, the inclusion of a length restriction 
for MUAC is likely a holdover from older versions of emergency nutrition guidelines that used 
length as a proxy for age (<6 months) because it can sometimes be difficult to ascertain age in a fast 
moving emergency. The WHO, for example, used length of 60 cm as a proxy for age of 6 months in 
publications from 1995 and 2000 
15,16
 while length of 65 cm was used in older versions of 
guidelines from non-governmental humanitarian organizations like Médecins Sans Frontières 
(MSF) in 1995 and Valid International in 2006 
17,18
. It is important to identify children <6 months 
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of age as they should be exclusively breastfed, and treated as in-patients if in need of treatment. 
However, length is a poor proxy for age, and most often a caretaker can recall the month of birth for 
an infant. 
Second, WHO now recommends against routine food supplementation of children with MAM due 
to a concern it may promote obesity and increase the risk of non-communicable diseases later in life 
19
. Some experts worry that shorter children above 6 months of age who only meet the low-MUAC 
criteria for MAM are at most at risk of excessive fat accumulation during treatment 
2
. Although 
only based on expert opinion, this seems to be the reason why many national malnutrition protocols 
exclude shorter children from having their MUAC measured, thereby making children ineligible for 
treatment, unless they meet WHZ criteria. This concern led WHO to call for research to identify 
appropriate MUAC admission and discharge criteria for children <67 cm and ≥6 months to 
supplementary feeding programs 
2
.  
We have previously shown, that when supplemented, ponderal growth rates are similar in short and 
long children ≥6 months with a low MUAC 
20
. Niger dropped this length restriction in 2016, and its 
revised protocols now call for measuring MUAC in all children ≥6 months, regardless of length 
21
. 
To what extent there is a difference in fat accumulation during treatment has not been assessed. The 
objective of this paper is to assess if short children (<67 cm) gain more fat than long children (≥67 
cm) when treated for MAM diagnosed by low MUAC (115-125 mm). 
 
SUBJECTS AND METHODS 
As previously reported 
20
, a prospective cohort study was nested in a randomized nutrition trial 
(Treatfood) 
22
 investigating the effectiveness of 500 kcal/day supplement either as corn-soy blend 
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(CSB) porridge or ready-to-use lipid-based nutrient supplements (LNS). The LNS supplements 
provided almost three times more energy as fat than the CSB supplements (~57% vs ~21%). 
Assignment to one of the 12 supplements (6 CSB and 6 LNS) followed randomisation stratified by 
site.  
Participants 
Data were collected in the Province du Passoré in the Northern region of Burkina Faso at 5 research 
sites located at different governmental health centers and staffed by the non-governmental 
organization Alliance for International Medical Action (ALIMA, Dakar, Senegal). 
Children were screened in villages either by community health workers using MUAC tapes or by 
designated screening teams with the use of both MUAC and WHZ. Moreover, children could be 
referred from a health centre or could present at site on caretaker´s initiative. At the sites, the final 
assessment of eligibility for inclusion was performed. 
For the main Treatfood trial, children aged 6–23 months with MAM (defined as MUAC between 
115-124 and/or a WHZ between –3 and –2), resident in the catchment area and whose caretaker 
consented to participate, were included. Children were not included if treated for severe acute 
malnutrition (SAM) or hospitalized within the past two months, if already in a nutritional program 
or if they presented medical complications requiring hospitalization. Likewise, children with a 
severe disability limiting the possibility of investigations and children with suspected allergy to 
milk, peanuts, corn or soy were not included.  
 
Of the 1609 children included in the trial 468 had MUAC between 115-125mm and WHZ ≥-2, and 
were included in the current study. In many settings these children are excluded from treatment if 
they are also short (i.e. <65 or 67 cm). Accordingly, children in this study were categorized, based 
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on baseline length, as SHORT (<67 cm) or LONG (≥67 cm) to assess if SHORT children gain more 
fat than LONG children when treated for MAM diagnosed by low MUAC. 
 
Procedures and study visits  
We previously described clinic visits, standard anthropometric measurements and age determination 
20
. In the present paper we additionally report on indices of body composition and skinfolds 
assessed at baseline and at end-intervention at 12 weeks. Total body water (TBW) was assessed 
using the deuterium dilution technique (D2O) to enable calculation of fat-free mass (FFM) and fat 
mass (FM). The method involved giving an oral dose of 5 g deuterium oxide (D2O) (99.8%, 
Cambridge Isotope Laboratories Inc., Andover, USA). The isotope was diluted in 5 g of bottled 
water (LAFI, Burkina Faso), with the dosing bottle weighed with 0.01 g precision (Adam 
equipment: model CQT 202, United Kingdom) before and after administration of the dose. Pre-dose 
saliva samples were obtained to assess background isotope levels in body fluids, and post-dose 
saliva samples were collected after a three-hour equilibration period as established during the pilot 
study 
23
. For each assessment, D2O enrichment was measured in duplicate in the pre- and post-dose 
saliva samples and in a diluted sample of the dose, using Fourier Transform Infrared Spectrometry 
(FTIR; Agilent Technologies, CA, USA) 
24
 at St. John's Research Centre, Bangalore, India. 
Saliva samples required at least 60 µl saliva for analysis. Deuterium dilution space was calculated 
as described previously 
25
, and converted to total body water (TBW) using a factor of 1·044 to 
adjust for proton exchange 
26
. FFM was calculated as TBW/hydration, using age- and sex-specific 
hydration coefficients 
27
. FM was calculated as weight minus FFM. Data were cleaned for 
typographical errors and implausible TBW values, based on the association of TBW with length 
and a cut-off for FM of <-0·1 and >2·4 kg. 
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Skinfold thickness was measured in duplicate by a Harpenden caliper. The mean of the duplicate 
measurements were taken for analysis. Weight was measured in duplicate to the nearest 100 g using 
electronic scales (Seca model 881 1021659) with double weighing function. Length was measured 
in duplicate with a wooden length board to the nearest 1 mm. WHZ was determined at sites using 
WHO field tables, and this value was used for recruitment. MUAC was measured in duplicate to the 
nearest 1 mm, at the midpoint between the olecranon and the acromion process using a standard 
measuring tape. Anthropometric measurements were undertaken by trained staff, after 
standardization sessions.  
In later analyses, WHZ, length-for-age z-score (LAZ) and weight-for-age z-score were calculated 
using the package “zscore06” in STATA 12 (College Station, Texas, USA). Skinfold-for-age z-
scores were calculated using WHO's Anthro Plus software (version 3.2.2, 2011, World Health 
Organization, Geneva, Switzerland). All z-scores were calculated using the 2006 WHO child 
growth standards. 
Outcomes 
Changes were evaluated in FM, FFM, weight, length, and skinfold thickness (both raw values and 
skinfold thickness-for-age z-scores). By dividing FFM and FM by length squared the indices are 
expressed as (kg/m
2
) independent of length, i.e. FFM index (FFMI) and FM index (FMI). In 
addition, fat was calculated as a percentage of total body weight.  
 
Statistical analysis 
Data were double entered in Epidata 3.1 (Epidata Association, Odense, Denmark) and double entry 
checks were performed on a daily basis. All statistical analyses were carried out using the statistical 
software package Stata version 12 (StataCorp, College station, Texas, USA). Baseline and endline 
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characteristics of children were summarized as mean (SD) or percentages, and categories were 
compared at baseline using two-sample t-tests for continuous variables and chi-square tests for 
categorical variables. 
To evaluate differences in outcomes between groups during the 12-week supplementation 
intervention, a linear mixed analysis of covariance model was considered as the main analysis, 
resulting in an estimated mean difference at the end of the study adjusted for differences at baseline. 
Specifically, the analyses included adjustment for food intervention as well as a number of baseline 
characteristics: baseline measure of the outcome, age, sex, and month of admission (as fixed 
effects). Random intercepts were included in the model to adjust for variation between sites. In the 
adjusted analysis, weight was derived by adding FFM and FM. Additionally, for direct outcomes of 
fat (FM and FMI) we evaluated the two-way interaction between length group and product group 
(CSB compared with LNS) in order to assess effect modification by type of product. Moreover, 
possible effect modification was also evaluated for stunting at admission in a) two categories: above 
and below LAZ of <-2, or b) or three categories: severe stunting (LAZ <-3), moderate stunting 
(LAZ ≥-3 to <-2) or absence of stunting (LAZ ≥-2). The same adjustments were applied in these 
additional analyses as in the main analysis. Model checking was based on residuals and normal 
probability plots. A significance level of 0.05 was applied. 
 
RESULTS 
A total of 1609 children, of which 55% were girls, were randomized to 12 weeks of supplementary 
feeding in the Treatfood trial 
22
. Of these, 50% (804) were included by both WHZ and MUAC, 21% 
(337) by WHZ alone and 29% (468) by MUAC alone. Among the 468 children recruited by MUAC 
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only, on whom this this paper is based, 230 (49%) were <67 cm (SHORT) and 238 (51%) ≥67 cm 
(LONG) 
20
. During the intervention, 3 SHORT and 11 LONG children dropped out prior to 
completion of supplementation at week 12. Body composition based on D2O dilution both at 
baseline and after 12 weeks were successfully determined in 195 (85%) of SHORT children and 
195 (82 %) of LONG children (Figure 1). At baseline, there were substantial differences in age and 
sex distributions, as well as in standard anthropometry between SHORT and LONG, whereas there 
were no differences in allocation to the different experimental diets and season of inclusion (Table 
1). Mean values of body composition variables determined at baseline and after supplementation are 
presented in Table 2. At baseline, the weight of SHORT children was 1.474 (95%CI: 1.355; 1.593) 
kg less than that of LONG children, which reflected a 0.120 (0.047; 0.193) kg lower FM and a 
1.354 (1.219; 1.489) kg lower FFM. Adjusted for length squared this corresponded to a 0.325 
(0.163; 0.487) kg/m
2  
higher FMI in SHORT compared to LONG children, but no difference (-0.056 
kg/m
2
, -0.230; 0.118) in FFMI. Body fat was 1.9 (0.8; 3.0) percentage points higher in SHORT 
compared to LONG children.  
Adjusted differences from baseline to endline are presented in Table 3. Following the 12 weeks of 
supplementation, there was no difference of change in FMI (-0.038 kg/m
2
, 95%CI -0.257; 0.181, 
p=0.74) or FFMI (0.061 kg/m
2
, 95%CI -0.150; 0.271; p=0.57) in SHORT vs LONG children. The 
SHORT children actually gained both less FFM (-230 g, 95%CI: -355; -106, p<0.001) as well as 
FM (-97 g, 95%CI -205; 10) although the latter was not significant (p=0.076). The differences in 
FM and FFM summed up to a 328 g (95%CI: 199; 456, p <0.001) lower weight gain in SHORT 
compared to LONG children. There were no differences in subscapular and triceps skinfold 
thickness and z-scores (all p>0.5). 
For FM and FMI there was no effect modification of product type, (CSB or LNS) (p>0.30). 
Likewise, there was no effect modification by stunting at admission (present or non-present) 
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(p>0.50) or stunting at admission stratified by severity (severe stunting, moderate stunting or non-
present) (p>0.45). 
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DISCUSSION 
In response to WHO´s call for research to identify appropriate MUAC admission and discharge 
criteria for children <67 cm and ≥6 months to supplementary foods 
2
, we show here that short 
children with MUAC 115-125 mm but WHZ >-2 do not gain excessive fat during supplementation. 
Our results therefore challenge current policy and practice in several African countries of measuring 
MUAC only in children more than 6 months of age above a certain length threshold, thus excluding 
shorter children with only low MUAC from eligibility for MAM or SAM treatment programs 
5–14
.  
The exclusion of short children is based solely on expert opinion, and reflects a concern that these 
children are just stunted rather than wasted, have slow catch-up growth, and may accumulate 
excessive fat mass following supplementation, thereby putting them at risk of non-communicable 
diseases later in life. We previously reported that ponderal growth rates were similar in short and 
long children who received supplementation for MAM determined only by low MUAC 
20
, and a 
similar finding was reported in children with SAM 
28
.  
The current study is the first to report direct evidence on fat accumulation following treatment for 
such children, and our data show there is no excessive fat gain in the SHORT children compared to 
LONG children. In fact, weight gain in both groups overwhelmingly came in the form of FFM. 
These findings were independent of children having received LNS or CSB supplement. Because 
LNS contains a high level of fat, some experts were concerned that this food could lead to higher fat 
deposition in the malnourished child. Earlier we showed that LNS did not lead to high fat 
accumulation in treatment of children for MAM 
22
. We now show that this concern is unwarranted 
even in shorter children enrolled in treatment solely by MUAC and, furthermore, is not modified by 
stunting at admission. 
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By using the state-of-the-art deuterium dilution technique seconded by skinfold thickness 
measurements, we present comprehensive data on body fat following supplementation in MAM. 
Since the gold standard for body composition is cadaver dissection, all in vivo techniques are 
necessarily imperfect. Here, we used two different techniques in which their error is uncorrelated, 
but their results are similar, making our findings more robust. 
At baseline, the SHORT compared to the LONG children were younger, contained more girls, had 
lower MUAC, and had higher prevalence of stunting and underweight, but were less wasted 
20
. 
More than 90% of the 1.5 kg higher weight in LONG children at baseline was FFM, while SHORT 
children had higher baseline FMI and fat%, and this was supported by higher baseline skinfold 
thicknesses. 
One possible explanation for this baseline difference is that, in the process of growing poorly, 
SHORT children invested relatively more in fat reserves than LONG children, at a cost to their 
functional fat-free tissue. However, a simpler alternative explanation is that even in children with 
optimal growth conditions, such as those used to establish WHO 2006 growth standards, both 
triceps and subscapular skinfold thicknesses tend to decrease in thickness between 6 months and 2 
years, and more so in boys than girls. Hence, the fact that the SHORT children were also ~6 months 
younger at baseline might explain the higher FMI at baseline. Supporting this, baseline skinfold 
thicknesses were thicker in SHORT children, but when expressed as z-scores relative to WHO 
reference data, SHORT children actually had lower triceps values than LONG children, while their 
subscapular skinfold thickness was only 0.2 z-score greater than in LONG children.  
At the end of the intervention, the average skinfolds thickness in this study were below -1 z-score in 
both groups suggesting no excessive fat gain in either group.  
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At the end of the supplementation relative measures of FMI, FFMI and percentage fat were similar 
between the two groups and likewise there was no difference between groups in skinfold thickness 
changes, whether expressed in absolute terms or as z-scores. The SHORT children gained less 
weight and FFM and also showed a trend towards less FM gain. 
A recent study found that children with MAM diagnosed solely on low MUAC experienced high 
rates of deterioration to SAM if left untreated 
29
. We are not aware of data on mortality data 
specifically for short children with MAM based only on low MUAC. However, the low MUAC 
SHORT children in our cohort exhibited high prevalence of additional anthropometric deficits. Half 
of the SHORT children were stunted and SHORT children were more underweight compared to 
LONG children. Stunted and underweight children have a higher mortality risk and may therefore 
benefit most from nutritional interventions 
30
. MUAC is a simple way to target them for treatment. 
The WHO recently updated its Integrated Management of Childhood Illness (IMCI), and now 
recommends against routinely supplementing children with MAM due to a concern for obesity. We 
previously showed that there was no excess fat accumulation in children with MAM supplemented 
with LNS or CSB 
22
. Our findings here show that even the shorter children with MAM determined 
solely by MUAC, who were considered by some experts to be at the greatest risk for obesity from 
food supplementation, do not become obese. Such children should no longer be excluded from 
treatment eligibility.  
We are not aware of any data on fat accumulation following treatment in short children with SAM 
by MUAC alone. Indeed, currently only data on skinfolds could be generated in large field studies 
in children with SAM, as current techniques available for body composition assessment are not 
suitable for use in SAM. However, we see no rationale in maintaining a length restriction for 
MUAC assessment in SAM.  
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In conclusion, SHORT children with low MUAC do not gain excessive fat during supplementation. 
Admission by the same MUAC criteria (i.e. <115 mm for SAM and 115-125 mm for MAM) should 
apply to any child 6-59 months of age, regardless of their length, and irrespective of their WHZ. 
The use of length as criterion for measuring MUAC should be discontinued in policy and practice 
wherever such restrictions exist. It will also be important for the WHO to integrate this evidence 
showing that children with MAM are not put at risk for obesity following food supplementation into 
its recently updated IMCI recommendations. 
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Figure 1 participant flow chart
a
 
 
 
 
 
 
 
 
 
 
a
 Treatfood participants included in the cohort study 
22
. 
b 
D2O = Body composition assessment by 
deuterium dilution technique  
 
Enrolled: n=1609 
Enrolled by WHZ and MUAC 
n=804 
Enrolled by MUAC alone 
n=468 
Enrolled by WHZ alone 
n=337 
Completed 12 weeks 
n=227 
SHORT (< 67 cm) 
n=230 
LONG (≥ 67 cm)  
n=238 
Completed 12 weeks 
n=227 
D2O
b
 complete     
n=195 
D2O complete    
n=195 
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Table 1. Baseline characteristics of children with moderate acute malnutrition included by MUAC 
only with complete D2O data (n=390), by length category
a
 
    
 
b
SHORT  
c
LONG  P-value 
  (n=195) (n=195)  
Girls, % (n) 84% (163) 72% (140) 0.005 
Age, months 7.7 (1.6) 14.0 (4.3) <0.001 
Weight, kg 6.012 (0.4) 7.487 (0.7) <0.001 
Length, cm  63.9 (2.1) 72.0 (3.9) <0.001 
Mid upper arm circumference, mm 121.0 (2.6) 122.2 (1.9) <0.001 
Weight for height z-score -1.5 (0.4) -1.7 (0.3) <0.001 
Weight for age z -2.4 (0.6) -2.1 (0.6) <0.001 
Length for age z -2.0 (1.0) -1.7 (1.0) 0.002 
Length for age z, <-2 % (n) 49% (95) 35% (68) 0.006 
    
Season at time of inclusion, % (n)   0.17 
Dry season 61% (118) 67% (131)  
    Rainy season 40% (77) 33% (64)  
Food supplement, % (n)   0.84 
CSB 48% (94) 47% (92)  
LNS 52% (101) 53% (103)  
Site, % (n)   0.009 
0 12% (24) 27% (52)  
1 15% (30) 11% (21)  
2 21% (41) 18% (35)  
3 31% (60) 26% (50)  
4 21% (40) 19% (37)  
Breastfeeding, % (n) 100% (194)  91% (178) <0.001 
    
a
Data are mean (±SD) unless otherwise indicated. 
b
SHORT <67 cm, 
c
LONG ≥67 cm. 
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Table 2. Body composition among short and long children with moderate acute malnutrition at baseline and endline, without 
adjustments
a
 
 Baseline 
 
Endline 
 
b
SHORT 
c
LONG 
 d
P ∆ 
 
SHORT LONG  
e
P ∆ 
  (n=195) (n=195)    (n=195) (n=195)   
Fat mass, kg 1.098 (0.4) 1.218 (0.4)  0.001  1.123 (0.4) 1.246 (0.4)  0.003 
Fat-free mass, kg 4.914 (0.5) 6.268 (0.8)  <0.001   5.673 (0.5) 7.096 (0.9)  <0.001 
%Fat, (Fat-mass/weight*100) 18.3 (5.8) 16.4 (5.3)  <0.001   16.3 (5.7) 15.0 (4.9)  0.015 
Fat mass index, kg/m
2
 2.689 (0.9) 2.364 (0.8)  <0.001  2.499 (0.9) 2.259 (0.8)  0.006 
Fat-free mass index, kg/m
2
 12.000 (0.9) 12.056 (0.9)  0.53  12.640 (0.8) 12.723 (0.9)  0.36 
Triceps skinfold, mm  6.6 (1.1) 6.3 (1.0)  0.001   6.8 (1.1) 6.8  (1.2)  0.85 
Triceps skinfold-for-age z -1.5 (0.8) -1.3 (0.8)  0.04  -1.1 (0.8)  - 0.8 (0.9)  0.007 
Subscapular skinfold, mm 5.6 (0.9) 5.1 (0.8)  <0.001   5.8  (1.0) 5.4 (0.8)  <0.001 
Subscapular skinfold-for-age z -1.3 (0.9) -1.5 (0.9)  0.03  -0.9 (1.0) -0.9 (0.9)  0.96 
          
a
Data are mean (±SD) unless otherwise indicated. 
b
SHORT <67 cm, 
c
LONG ≥67 cm.
 d
P value for difference at baseline between SHORT and 
LONG children.
 e
P value for difference at endline between SHORT and LONG children. 
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Table 3. Changes in outcomes during supplementation
a
 
 
b
SHORT 
c
LONG 
d
Difference in change  
e
P ∆ 
  (n=195) (n=195)   
Fat mass, kg -0.022 (-0.088; 0.043) 0.075 (0.010; 0.140) -0.097 (-0.205: 0.010) 0.076 
Fat-free mass, kg 0.678 (0.604; 0.752) 0.908 (0.834; 0.982) -0.230 (-0.355; -0.106) <0.001 
%Fat (Fat-mass/weight*100) -1.8 (-2.6; -1.0) -1.5 (-2.3; -0.7) -0.3 (-1.6; 1.1) 0.70 
Fat mass index, kg /m
2
 -0.166 (-0.309; -0.234) -0.128 (-0.271; 0.015) -0.038 (-0.257; 0.181) 0.74 
Fat-free mass index, kg/m
2
 0.684 (0.556; 0.813) 0.624 (0.495; 0.752) 0.061 (-0.150; 0.271) 0.57 
Triceps skinfold, mm  0.39 (0.04; 0.73) 0.35 (-0.002: 0.70) 0.04 (-0.24; 0.32) 0.77 
Triceps skinfold-for-age z 0.48 (0.25; 0.71)  0.50 0.26; 0.73) -0.02 (-0.22; 1.85) 0.88 
Subscapular skinfold, mm 0.32 (0.17; 0.47) 0.24 (0.09; 0.40) 0.08 (-0.15; 0.30) 0.52 
Subscapular skinfold-for-age z 0.52 (0.36; 0.67) 0.49 (0.34; 0.65) 0.02 (-0.21; 0.26) 0.84 
     
a
Data are mean and 95% CI calculated using linear mixed models adjusted for food intervention, baseline measure of the outcome, age, 
sex, month of admission and site (random effects).
b
SHORT <67 cm, 
c
LONG ≥67 cm. 
d
Difference in change of SHORT vs LONG. 
e
P value for 
difference in change from baseline to endline for SHORT and LONG children. 
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based on baseline length, as SHORT (<67 cm) or LONG (≥67 cm) to assess 
if SHORT children gain more fat than LONG children when treated for 
MAM diagnosed by low MUAC .” 
 
 
3. Thanks for pointing this out. The problem is that “
22” 
is a reference 
in “Pediatrics” format. To improve readability we now changed 
table superscripts to letters. 
 
4. Thanks. MAM is now written as moderate acute malnutrition. 
 
 
1. Title 
2. In statistical 
analysis 
3. In 
Participants 
4. Tab 1 +2 
 
    
Reviewer 2´ comment We thank reviewer 2 for the kind comments on our study and for us 
testing BOGSAT opinion 
  
    
Reviewer 3´s comment We thank reviewer 3 for the very positive review  1 In statistical  
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1. Methodology: Were the mixed 
models “random intercept” or 
“random intercept” and “random 
slope” models?  
 
2. Results: How were the results 
(mean difference, 95% CI and P-
value) for weight gain obtained? For 
me is not clear: why as the weight 
difference between end of 
intervention and baseline not used? 
 
3. Discussion: Are there potential 
bias that could limit the 
generalization of the results?  
 
4. Are other studies needed to 
validate the results from this study?  
 
5. Is it possible that these 
supplemented children develop 
obesity later in childhood or 
adolescence? 
 
 
1. We’ve now clarified that the linear mixed models only included 
random intercepts corresponding to the sites. The text now reads:   
“To evaluate differences in outcomes between groups during the 12-week 
supplementation intervention, a linear mixed analysis of covariance 
model was considered as the main analysis, resulting in an estimated 
mean difference at the end of the study adjusted for differences at 
baseline. Specifically, the analyses included adjustment for food 
intervention as well as a number of baseline characteristics: baseline 
measure of the outcome, age, sex, and month of admission (as fixed 
effects). Random intercepts were included in the model to adjust for 
variation between sites. In the adjusted analysis, weight was derived by 
adding FFM and FM. Additionally, for direct outcomes of fat (FM and FMI) 
we evaluated the two-way interaction between length group and product 
group (CSB compared with LNS) in order to assess effect modification by 
type of product. Moreover, possible effect modification was also 
evaluated for stunting at admission in a) two categories: above and below 
LAZ of <-2, or b) or three categories: severe stunting (LAZ <-3), moderate 
stunting (LAZ ≥-3 to <-2) or absence of stunting (LAZ ≥-2). The same 
adjustments were applied in these additional analyses as in the main 
analysis. Model checking was based on residuals and normal probability 
plots. A significance level of 0.05 was applied.” 
 
2. Thanks for the question. Weight gain was estimated using the 
weight measurements at the end of the study but adjusted for 
baseline weight (analysis of covariance). We’ve now spelled out 
that we used an analysis of covariance type of linear mixed model. 
In this way, confidence  intervals and p-values were obtained 
directly from the model fits (This is included in text in the paper as 
seen in the answer to your first question) 
 
3. We don’t consider bias to be a problem in this study. First, 
selection bias is unlikely, since we included a large proportion of 
analysis 
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those with MAM, based on MUAC, in the study, and the follow-up 
rate was very high, and not different between the two groups 
being compared. Hence, it is unlikely that selection could have led 
to a bias because of, say, lower probability of inclusion/higher 
attrition of children more prone to accumulate fat in the short 
compared to the long children. Second, information bias is unlikely 
since the outcome was assessed in the lab by staff who were 
unaware of the exposure of interest. Theoretically, a source of 
information bias could be that short children were more or less 
likely to spit when given the deuterium. For example, if short 
(younger) children were more likely to spit, then the concentration 
of deuterium would be underestimated, and the total body water 
overestimated, and therefore, the fat mass would be 
underestimated. However, since this would then happen base at 
baseline and endline, it is not likely to affect the change in fat 
mass, which is our outcome of interest. In general, generalizability 
is likely to be lower in nutrition compared to other intervention 
trials, since the effect of an intervention depends on the 
background nutritional intake and status. However, in this 
substudy, we are not testing the effect of a nutrition intervention, 
but if short stature affects changes in body composition. Certainly, 
since we used strict inclusion criteria we think that our findings 
can be generalized to other West African populations of young 
children with MAM, diagnosed using MUAC, at least. Yet, we 
cannot exclude the possibility that different fetal and early life 
trajectories in growth and body composition, as well as differences 
in background diets, may modify the difference in change in body 
composition during supplementation.                                               
This paper specifically asks for a policy change in the remaining 
African countries where length restriction is applied to MUAC 
measurements, these countries are located in West and Central 
Africa where morbidity/mortality and malnutrition patterns (very 
high incidence of acute malnutrition accompanied by high levels of 
stunting) are similar to that seen in Burkina. We would welcome 
further studies.  It is probably worthwhile to repeat such body 
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composition studies in other malnutrition contexts such as high 
prevalence of kwashiorkor in DRC/East Africa and in South Asia. 
However, we feel that policy must be changed now as no evidence 
support fat accumulation in this group of children.                              
Given the fact that we are already at the full word limit we hope it 
is acceptable that we make no further changes in the manuscript 
text. 
 
4. This is a very good question. Malnutrition in itself might dispose to 
later non-communicable diseases (NCD) including increased 
susceptibility to fat accumulation, but firm evidence is lacking. 
However, if children with MAM are not treated, they are at a 3 
times higher risk of dying here and now. The fact that they do not 
accumulate excess fat directly following 12 weeks treatment 
indicates, we believe, that the risk of later obesity following 
modern supplementation is, if at all present, low.  The longer term 
implications of nutritional supplementation on NCD risk would be 
more likely to emerge in studies of young children supplemented 
over longer periods, e.g. the 9-18 month. However, the only way 
to find out would be doing long-term follow-up and compare our 
present cohort with another cohort who received different or no 
supplementation.  
Also, while getting fat later increases NCD risk, so does losing lean 
mass early, ie the thrifty phenotype. So, it makes sense to try to 
address the lean deficit when it is still amenable to nutritional 
therapy (early critical window).                                                        
Given the fact that we are already at the full word limit we hope it 
is acceptable that we make no further changes in the manuscript 
text.                                                
 
 
Instructions: 
Please use this table format to answer the questions posed by the editors and reviewers of your paper. Copy and paste the editor/reviewer’s question in the  
“Comments” column and your answer to that question in the corresponding “Response” column. Be sure to ALSO paste the corrected text along with your response. 
For minor copyediting changes such as spelling and grammar corrections, you may simply state that the error was corrected, without pasting the altered text. 
* Use the page/line numbers from your revised .doc, .rtf, or .txt file; do not use the page/line numbers from the submission system’s auto-generated PDF.  
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For clarity, use one row per question. Make sure to list the page and line reference where your change can be found. If no change was made, please make sure to note 
that in your response in addition to your reasoning. You may delete the sample row and insert rows to this table as needed.   
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